Results 31 to 40 of about 2,710 (195)

Modified insertion technique for a sustained-release dexamethasone intravitreal implant (Ozurdex®)

open access: yesAmerican Journal of Ophthalmology Case Reports, 2020
Purpose: We describe a modified injection technique that adheres a sustained-release dexamethasone intravitreal implant (Ozurdex®) to the vitreous base.
Daniel H. Lee, Clement K. Chan
doaj   +1 more source

Local safety of repeated intravitreal Ozurdex [PDF]

open access: yesEye, 2013
Sir, The article entitled ‘Twelve-month experience with Ozurdex for the treatment of macular edema associated with retinal vein occlusion'1 highlights the significant cataract progression in eyes receiving more than one Ozurdex implant. We retrospectively reviewed the charts of all patients with macular edema secondary to retinal vein occlusion (RVO)
P, Hernández-Martínez   +4 more
openaire   +2 more sources

Ocular hypertension and its predictor after a single Ozurdex implant: One-year follow-up in Asian Indian eyes

open access: yesOman Journal of Ophthalmology, 2022
BACKGROUND: To determine the incidence and risk factors for an increase in the intraocular pressure (IOP) after a single dexamethasone intravitreal implant (Ozurdex). MATERIALS AND METHODS: Medical records of 41 consecutive eyes who had received a single
Tarannum Mansoori   +2 more
doaj   +1 more source

Iatrogenic intralenticular broken steroid implant: a case report

open access: yesJournal of Medical Case Reports, 2019
Background This is a case report of an iatrogenic intralenticular broken steroid (Ozurdex™) implant in a patient with uveitis. There are only a few case reports on broken Ozurdex™ implants in the vitreous cavity, with none of them involving the ...
Jun Fai Yap   +3 more
doaj   +1 more source

Acute retinal necrosis following dexamethasone intravitreal implant (Ozurdex®) administration in an immunocompetent adult with a history of HSV encephalitis: a case report

open access: yesBMC Ophthalmology, 2020
Background Dexamethasone intravitreal implants (0.7 mg) (Ozurdex®, Allergan Inc., Madison, NJ) are FDA approved for managing macular oedema (ME) of retinal vein occlusion (RVO).
Zhi-Yong Zhang, Xiu-Yun Liu, Tao Jiang
doaj   +1 more source

Intravitreal Dexamethasone Implant (Ozurdex) in Coats' Disease [PDF]

open access: yesCase Reports in Ophthalmology, 2013
We injected an intravitreal dexamethasone implant in two eyes of 2 pediatric patients with Coats' disease in addition to other treatment modalities, such as intravitreal ranibizumab injection and indirect laser photocoagulation. In both eyes, intraocular pressure moderately rose in a temporary fashion.
SAATCİ, ALİ OSMAN   +2 more
openaire   +4 more sources

Central Retinal Vein Occlusion treated with Ozurdex: a case report and review of literature

open access: yes, 2012
Purpose: To describe the retinal changes occurring after Ozurdex(®) (Ozurdex, Allergan, Inc., Irvine, CA) injection and peripheral laser treatment in a case of central retinal vein occlusion (CRVO).
SEMERARO, Francesco   +7 more
core   +2 more sources

Intravitreal Ozurdex has no short term influence on choroidal thickness and vascularity index in eyes with diabetic macular edema: A pilot study

open access: yesOman Journal of Ophthalmology, 2021
AIM: To analyze choroidal parameters in eyes with diabetic macular edema (DME) treated with intravitreal Ozurdex. PATIENTS AND METHODS: Twenty eyes of 14 patients were included in this prospective study.
Pukhraj Rishi   +6 more
doaj   +1 more source

Vitreoretinal surgery for inadvertent intralenticular Ozurdex implant [PDF]

open access: yesEye, 2014
Sir, We read with interest the recent report by Chhabra et al.1 We would like to share a similar rare case that required early vitreoretinal intervention. In our case, a 62-year-old with left branch retinal vein occlusion and macular oedema underwent an Ozurdex injection in another eye unit.
K, Chalioulias, M M K, Muqit
openaire   +2 more sources

Secondary ocular hypertension post intravitreal dexamethasone implant (OZURDEX) managed by pars plana implant removal along with trabeculectomy in a young patient

open access: yesOman Journal of Ophthalmology, 2020
We report a case of refractory secondary ocular hypertension after insertion of dexamethasone implant (OZURDEX) for posterior uveitis in a young patient, which necessitated removal of the implant through pars plana vitrectomy along with a trabeculectomy.
Rathini Lilian David, Parveen Sen
doaj   +1 more source

Home - About - Disclaimer - Privacy